Supplementary Material for: Changes in migraine symptoms after ischemic stroke: a cohort study by vanderWeerd N. (18602434)

“…Change in migraine symptomatology was reported by 63 (81%) patients; 51 (81%) noticed a decrease in attack frequency (27 no attacks), and 12 (19%) an increase. …”

Representative in vivo T1, T2* and merge-weighted MRI images of control mice and mice with EAE before and after gadolinium (Gd) and NPS-P88. by Juan F. Zapata-Acevedo (18349423)

DMOG treatment affects worm body morphology in a dose-dependent manner. by Megan M. Braun (8201181)

“…<p>A. Midpoint width increases with increasing DMOG dose. …”

Supplementary Material for: Management and Survival of Pleural Mesothelioma: A Record Linkage Study by Carioli G. (4838469)

“…OS was 45.4% at 1 year, 24.8% at 2 years, and 9.6% at 5 years (median 11 months). OS decreased with age, and was higher for those who underwent surgery, but not for those treated with chemotherapy. …”

A New Functional MRI Approach for Investigating Modulations of Brain Oxygen Metabolism by Valerie E. M. Griffeth (278482)

“…If more specific information regarding changes in CMRO₂ is required, then with accuracy similar to that of the Davis model, the heuristic model can be applied to calibrated BOLD data at 1.5T, 3T and 7T. Both models work well over a reasonable range of blood flow and oxygen metabolism changes but are less accurate when applied to a simulated caffeine experiment in which CBF decreases and CMRO₂ increases.…”

Representative in vivo T2*-weighted MRI images of control mice and mice with EAE before and after NPS-P88 injection. by Juan F. Zapata-Acevedo (18349423)

Designing Reaction Coordinate for Ion-Induced Pore-Assisted Mechanism of Halide Ions Permeation through Lipid Bilayer by Umbrella Sampling by Anjana V. Mathath (17552017)

Metformin lotion inhibits the release of HMGB1 from cell nuclei to the skin tissue matrix in rats. by Jianying Zhang (256508)

All raw data support findings of the study. by Bickes Wube (21678222)

“…Groups IV and V were used as pair-fed and ad libitum controls, respectively. …”

The Proteasome as a Drug Target in the Metazoan Pathogen, <i>Schistosoma mansoni</i> by Betsaida Bibo-Verdugo (4273624)

“…After 24 h, bortezomib and carfilzomib decreased worm motility by more than 85% and endogenous proteasome activity by >75%, and after 72 h, they increased caspase activity by >4.5-fold. …”

Statins and Hip Fracture Prevention – A Population Based Cohort Study in Women by Arja Helin-Salmivaara (123653)

“…In the hypertension and the population cohorts, the rates were 2.0 per 1000 py (312 fractures per 157 090 py) and 1.0 per 1000 py (212 fractures per 216 329 py), respectively. Adjusting for a propensity score and individual variables strongly predicting the outcome, good adherence to statins for five years was associated with a 29% decreased risk (HR 0.71; 95% CI 0.58–0.86) of a low-energy hip fracture in comparison with adherent use of hypertension drugs. …”

The Proteasome as a Drug Target in the Metazoan Pathogen, <i>Schistosoma mansoni</i> by Betsaida Bibo-Verdugo (4273624)

“…After 24 h, bortezomib and carfilzomib decreased worm motility by more than 85% and endogenous proteasome activity by >75%, and after 72 h, they increased caspase activity by >4.5-fold. …”

The Proteasome as a Drug Target in the Metazoan Pathogen, <i>Schistosoma mansoni</i> by Betsaida Bibo-Verdugo (4273624)

“…After 24 h, bortezomib and carfilzomib decreased worm motility by more than 85% and endogenous proteasome activity by >75%, and after 72 h, they increased caspase activity by >4.5-fold. …”

The Proteasome as a Drug Target in the Metazoan Pathogen, <i>Schistosoma mansoni</i> by Betsaida Bibo-Verdugo (4273624)

“…After 24 h, bortezomib and carfilzomib decreased worm motility by more than 85% and endogenous proteasome activity by >75%, and after 72 h, they increased caspase activity by >4.5-fold. …”

Impact of Draw Solution Concentration on Forward Osmosis Process: A Simulation Study by Alfahel, Radwan

“…Also, while increasing concentration of draw solution, energy consumption decreased. The maximum recovery rate of 33% was achieved using (0.5M NaCl) draw solution and a flow rate of 40000 m3/day. …”
Get full text
Get full text

Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure–Activity Relationships of the Novel PPP4pT Series by Tharushi P. Wijesinghe (17334832)

Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure–Activity Relationships of the Novel PPP4pT Series by Tharushi P. Wijesinghe (17334832)

Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure–Activity Relationships of the Novel PPP4pT Series by Tharushi P. Wijesinghe (17334832)

Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure–Activity Relationships of the Novel PPP4pT Series by Tharushi P. Wijesinghe (17334832)

Steric Blockade of Oxy-Myoglobin Oxidation by Thiosemicarbazones: Structure–Activity Relationships of the Novel PPP4pT Series by Tharushi P. Wijesinghe (17334832)